Automated Immunoassay Analyzers Market
Automated Immunoassay Analyzers Market (Technology - Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), and Radioimmunoassay (RIA); Sales Model - Reagent Rental / Lease and Outright Sale; End User - Hospitals, Diagnostic Laboratories, and Blood Bank) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025
- Category : Healthcare
- Format :
Press Release :
Use of biochemical testing technologies in the medical industry has aided the growth of the global automated immunoassay analyzers market. The relevance of conducting diagnostic tests in the healthcare industry cannot be underestimated. Several sub-domains within healthcare have invested in developing sound and effective diagnostic tests. Furthermore, these sub-domains have also been involved in sampling and analysis of substances used for medical analysis. The recent uptick in revenues caused across the field of clinical research has given an impetus to the growth of the global automated immunoassay analyzers market. Therefore, it is safe to state that hospitals and clinical laboratories are the primary consumers within the global immunoassays industry.
- The rising incidence of chronic diseases related to the liver, kidneys, and blood have raised concerns across the medical industry. Several new diagnostic technologies have been developed across the medical industry. Amongst these technologies, immunoassays continue to be the most sought-after means of conducting medical tests.
- Use of the right reagents and dilution methods while engaging immunoassay analyzers has also gained popularity in recent times. The quest of the medical industry to complete diagnostic tests at palpable speeds and with deft accuracy shall bring automated immunoassay analyzers under the spotlight of attention.
- The Food and Drug Administration (FDA) has played an integral role in driving sales across the global automated immunoassay analyzers market. The FDA is also responsible for authenticating protein analyzers. The aforementioned trends are suggestive of the inflow of fresh revenues into the global automated immunoassay analyzers market. Some of the common applications of immunoassays span into drug monitoring, allergy testing, cardiac analysis, and infection diagnosis.
Investments made by the medical industry towards diagnosis and diseases analysis has created new pathways for market expansion. Therefore, the revenues index of the global automated immunoassay analyzers market is projected to rise by leaps and bounds
Global Automated Immunoassay Analyzers Market: Snapshot
Immunoassay is a technique or method to detect presence of a particular substance in the human body may be an antigen, antibody, pathogen, hormone, or an enzyme. Immunoassay is based on the principle of antigen and antibody specificity. Immunoassays have been in use in the field of clinical chemistry from a long time. They are being widely used owing to their specificity and rapid test time. Beside clinical diagnostic, immunoassays are being widely used in field of research and development and quality control in pharmaceutical & biotechnology and food & beverages industry. Technological advancements, increasing test volume and shortfall of skilled workforce has led to development of automated immunoassay analyzers. These system perform all the procedures indigenously such as sample preparation, reagent and assay mixing, washing & rinsing, signal detection and result generation.
Aging population, increasing incidences of infectious disease epidemics such as Zica disease, hepatitis infection, HIV and others is likely to drive expansion of automated immunoassay analyzers market during the forecast period from 2017 to 2025. Trend of laboratory consolidation and preventive health care is augmenting the rise in test volume which is leading to demand for laboratory automation and integration. Moreover, demand for international standardization and result comparability is fueling this demand across the globe. Automated immunoassay analyzer is a capital equipment which attract high cost and quality infrastructure. Cost constraint among diagnostic laboratories in developed markets due to declining re-imbursements is likely to hamper the growth of global automated immunoassay analyzers market.
Demand for Chemiluminescence Immunoassay to Rise Significantly in Near Future
Based on technology, the global automated immunoassay analyzers market is segmented into chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and others. The CLIA analyzers segment is estimated to account for a leading share of global automated immunoassay analyzers market and register an exponential growth during the forecast period. The others segment which include technologies such as biochip assay, counting immunoassay, immunofluorescent assay (IFA) is estimated to have moderate growth rate from 2017 to 2025.
On the basis of sales model, the global automated immunoassay analyzers market is divided into reagent rental or lease and outright sale segment. The outright sale segment is projected to register highest CAGR during 2017-2025, owing to the increasing focus of key players on this sales model to enhance their cash flows and avoid recurring cost on services and maintenance. Based on end-user, the global market is segmented into hospitals, diagnostic laboratories, blood banks and others. The diagnostic laboratories is segment is estimated to account for leading share of the market and register highest CAGR during the forecast period from 2017 to 2025.
Demand from North America to Significantly Contribute to Overall Market’s Growth
Geographically, global automated immunoassay analyzers market is divided into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global automated immunoassay analyzers market in terms of value in 2016. The region is estimated to remain dominant during the forecast period, due to strategic presence of key manufacturers. High adoption of technology in the U.S., and rising demand for clinically efficient immunoassay analyzers are the major factors for the estimated growth of venous stents in North America by 2025. However, Asia Pacific is likely to grow with relatively significant CAGR during 2017-2025, due to rising investment by public & private players for the betterment of healthcare services in Asia Pacific region.
Globally, major players operating in the development, manufacturing, and commercialization of automated immunoassay analyzers are Siemens Healthineers, Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Ortho Clinical Diagnostics, Radiometer APS, Randox Laboratories, F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., SNIBE Diagnostics, Sysmex Corporation and Thermo Fisher Scientific.
Global Automated Immunoassay Analyzers Market: Overview
This report on the global automated immunoassay analyzers market analyzes the current and future scenario of the global market. Ageing population and increasing incidences of chronic diseases and infection epidemics such as Zica diseases, hepatitis, HIV infection, etc. is poised to rise the test volume in diagnostic laboratories. Moreover increasing demand for preventive health care and rise in private health care expenditure is estimated to augment this growth. Availability of alternative promising diagnostic tools such as molecular diagnostics and mass spectrometry is estimated to hamper the growth of automated immunoassay analyzers market during the forecast period from 2017 to 2025.
Global Automated Immunoassay Analyzers Market: Scope of Study
The global automated immunoassay analyzers market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on technology, sales model, end-user, and geography. A detailed qualitative analysis of drivers and restraints, opportunities and trends has been provided in the market overview section. Additionally, the section comprises industry evolution and key events occurred in recent years in global automated immunoassay analyzers market. An overview of key strategies adopted by top 3 players in global automated immunoassay analyzers market. This report also provides market attractiveness and its analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global automated immunoassay analyzers market.
Global Automated Immunoassay Analyzers Market: Key Segments
Based on the technology, the global market has been segmented into Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), and Others. CLIA technology is estimated to account for leading share of global automated immunoassay analyzers market owing to their vast assay availability, comparatively low cost and high through put. The market size and forecast in terms of value (US$ Mn) and volume (units) for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Different types of sales models in the automated immunoassay analyzers market are reagent rental / lease and outright sale. Outright sale model is projected to register exponential growth during the forecast period and account for significant share of the global automated immunoassay analyzers market. This growth is attributed by increasing focus of key players in outright sale of their analyzers to improve their cash flows and avoid recurring cost on services and maintenance of the system.
Based on end-user, the global automated immunoassay analyzer market is segmented into four major segments, which are hospitals, diagnostic laboratories, blood banks and others. Others segment comprised of research institutes, pharmaceutical & biotechnology industry and food and beverages industry. The diagnostic laboratories segment is anticipated to register highest growth rate and account for leading market share during the forecast period.
Global Automated Immunoassay Analyzers Market: Regional Outlook
Geographically, the global automated immunoassay analyzers market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa).
Companies Mentioned in Report
The report also profiles major players in the global automated immunoassay analyzers market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Siemens Healthineers, Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Ortho Clinical Diagnostics, Radiometer APS, Randox Laboratories, F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., SNIBE Diagnostics, Sysmex Corporation and Thermo Fisher Scientific.
The Global Automated Immunoassay Analyzers Market has been segmented as given below:
|
by Technology |
|
|
by Sales Model |
|
|
by End User |
|
|
by Region |
|
